new glp-1 drug retatrutide Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Unapproved weight loss drug retatrutide
Description
B., Cuervo, A
Understanding GIP: The Second Incretin GIP received less attention initially than GLP-1 because early research suggested it might not be useful for diabetes treatment
People taking GLP-1 receptor agonists may become dehydrated from vomiting or diarrhea, causing kidney problems
However, a significant increase in Bifidobacterium, Dialister , and Alistipes was reported (73)
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
